VisionSense

Stereoscopic Sight for Minimally Invasive Surgery

Health Tech & Life Sciences
Acquired (Inactive) by Medtronic on Apr 2018 - closed due to acquisition

Company Overview

Snapshot

Founded in July 1998, VisionSense developed visualization solutions for minimally invasive surgery. The company was acquired by Medtronic in April 2018.

Business overview

VisionSense specializes in developing advanced visualization solutions that provide natural stereoscopic sight for minimally invasive surgical procedures. Leveraging sensor technology and proprietary software, the company's system delivers depth perception, 3D HD-resolution images, and flexible maneuvering within small access diameters. Its VSiii solution, a small-diameter single-channel endoscope, is designed for use in neurosurgery, ENT, arthroscopy, and general surgery, enhancing surgeons' tissue understanding and hand-eye coordination. VisionSense operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics.

Strategic signal

In April 2018, VisionSense was acquired by Medtronic for an estimated $65-75 million. This acquisition highlights the strategic importance of advanced visualization and stereoscopic imaging technologies in the medical device industry, signaling Medtronic's intent to enhance its offerings in minimally invasive surgery and potentially integrate VisionSense's innovations into its broader surgical platforms.

Company Intelligence Q&A

What is VisionSense's core technology?
VisionSense's core technology involves visualization solutions that provide natural stereoscopic sight for minimally invasive surgery, utilizing sensor technology and proprietary software to deliver 3D HD-resolution images and depth perception.
When was VisionSense acquired?
VisionSense was acquired by Medtronic in April 2018.
What was the reported acquisition price for VisionSense?
Medtronic reportedly bought VisionSense for $65 million to $75 million in April 2018.
What is the VSiii solution?
The VSiii solution is a small-diameter, single-channel endoscope developed by VisionSense that delivers visual information to a stereoscopic camera, enabling enhanced visualization for minimally invasive neurosurgery, ENT, arthroscopy, and general surgery procedures.
Did VisionSense file any patent-related actions?
In May 2017, VisionSense filed for an Inter Partes Review (IPR) against Novadaq's US Patent 8,892,190.

External links